I agree that this site is using cookies. You can find further informations here.
X
Morita, Mitsunori
302  results:
Search for persons X
?
1

A survey of carboplatin desensitization therapy in Japan: A..:

Komatsu, Hiroaki ; Matsumoto, Koji ; Morita, Mitsunori...
Cancer Medicine.  13 (2024)  5 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
2

Classification and regression tree for estimating predictiv..:

Tamiya, Motohiro ; Fujikawa, Kei ; Suzuki, Hidekazu...
Investigational New Drugs.  40 (2022)  2 - p. 361-369 , 2022
Link: https://doi.org/10.1007/..
 
?
3

Clinical factors associated with shorter durable response, ..:

Hosoya, Kazutaka ; Fujimoto, Daichi ; Morimoto, Takeshi...
BMC Cancer.  21 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
4

Prediction of patients with a tumor proportion score > 50% ..:

Morita, Mitsunori ; Tamiya, Motohiro ; Fujimoto, Daichi...
BMC Cancer.  20 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
5

Association Between Early Immune-related Adverse Events and..:

Hosoya, Kazutaka ; Fujimoto, Daichi ; Morimoto, Takeshi...
Clinical Lung Cancer.  21 (2020)  4 - p. e315-e328 , 2020
Link: https://doi.org/10.1016/..
 
?
6

Nivolumab for advanced non-small cell lung cancer patients ..:

Fujimoto, Daichi ; Yomota, Makiko ; Sekine, Akimasa...
Lung Cancer.  134 (2019)  - p. 274-278 , 2019
Link: https://doi.org/10.1016/..
 
?
7

Infective endocarditis presenting as diffuse alveolar hemor..:

Morita, Mitsunori ; Tomioka, Hiromi
Respiratory Medicine Case Reports.  28 (2019)  - p. 100931 , 2019
Link: https://doi.org/10.1016/..
 
?
8

Efficacy and safety of pembrolizumab as first-line therapy ..:

Tamiya, Motohiro ; Tamiya, Akihiro ; Hosoya, Kazutaka...
Investigational New Drugs.  37 (2019)  6 - p. 1266-1273 , 2019
Link: https://doi.org/10.1007/..
 
?
9

Association between metastatic sites and first-line pembrol..:

Kawachi, Hayato ; Tamiya, Motohiro ; Tamiya, Akihiro...
Investigational New Drugs.  38 (2019)  1 - p. 211-218 , 2019
Link: https://doi.org/10.1007/..
 
?
10

Clinical outcomes in non-small cell lung cancer patients wi..:

Edahiro, Ryuya ; Kanazu, Masaki ; Kurebe, Hiroyuki...
PLOS ONE.  14 (2019)  7 - p. e0220570 , 2019
Link: https://doi.org/10.1371/..
 
?
11

Efficacy and safety of nivolumab in previously treated pati..:

Fujimoto, Daichi ; Yoshioka, Hiroshige ; Kataoka, Yuki...
Lung Cancer.  119 (2018)  - p. 14-20 , 2018
Link: https://doi.org/10.1016/..
 
?
12

Serum albumin level as a potential marker for deciding chem..:

Ikeda, Satoshi ; Yoshioka, Hiroshige ; Ikeo, Satoshi...
BMC Cancer.  17 (2017)  1 - p. , 2017
Link: https://doi.org/10.1186/..
 
?
13

P2.06-015 The NICE Salvage Study: A Phase II Trial of Weekl..:

Niwa, Takashi ; Yoshioka, Hiroshige ; Hata, Akito...
Journal of Thoracic Oncology.  12 (2017)  1 - p. S1078-S1079 , 2017
Link: https://doi.org/10.1016/..
 
?
14

Interstitial lung disease in clinically amyopathic dermatom..:

Ikeda, Satoshi ; Arita, Machiko ; Morita, Mitsunori...
BMC Pulmonary Medicine.  15 (2015)  1 - p. , 2015
Link: https://doi.org/10.1186/..
 
?
15

Successful Treatment of Fulminant Community-Acquired Pseudo..:

Kunimasa, Kei ; Ishida, Tadashi ; Kimura, Soichiro...
Internal Medicine.  51 (2012)  17 - p. 2473-2478 , 2012
Link: https://doi.org/10.2169/..
 
1-15